Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Glucagon for Hypoglycemia in Children and Adolescents
NCT02402933Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Mar 2015
- Primary completion
- Aug 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of glucagon in hypoglycemia, sponsored by Eli Lilly and Company. Started Mar 2015; status: completed.
02
Drugs
glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT02402933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02402933.